News Focus
News Focus
icon url

gym gravity

09/04/07 10:33 AM

#4888 RE: croumagnon #4887

don't forget, silent black helicopters.
icon url

DewDiligence

09/04/07 10:36 AM

#4889 RE: croumagnon #4887

Priority Review can be granted—and often is granted—without Fast Track; hence I don’t agree that Fast Track per se is highly consequential.

>Additionally, receiving fast-track designation gets the company to have a lot more collaboration and meetings with the FDA about ATryn…<

This is an advantage when a drug program is still in its early stages. In the case of ATryn, however, the important feedback from the FDA was obtained when the company and the FDA agreed on the design of the phase-3 trial.
icon url

ThomasS

09/04/07 7:02 PM

#4923 RE: croumagnon #4887

I imagine his comment was directed at those who immediately pushed the "buy" button at 0831 to purchase at $1.40 or so... only to see their testosterone-induced investment lose 20% ina matter of hours. We've all done it before and, hopefully, learned from the experience. (Not today, tho!)
I wouldn't presume to speak for DewD, however.